Sean Turner

1.0k total citations
38 papers, 447 citations indexed

About

Sean Turner is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Organic Chemistry. According to data from OpenAlex, Sean Turner has authored 38 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pediatrics, Perinatology and Child Health and 10 papers in Organic Chemistry. Recurrent topics in Sean Turner's work include Pharmaceutical studies and practices (13 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Ion channel regulation and function (5 papers). Sean Turner is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Ion channel regulation and function (5 papers). Sean Turner collaborates with scholars based in United States, Australia and United Kingdom. Sean Turner's co-authors include Henry Rapoport, Mark G. Moloney, Jack E. Baldwin, Hongbin Zhai, Jaesung Choi, Ying‐zi Xu, Christophe Henry, Manuel Calaza, Murali Gopalakrishnan and Michael J. Coghlan and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and British Journal of Pharmacology.

In The Last Decade

Sean Turner

38 papers receiving 437 citations

Peers

Countries citing papers authored by Sean Turner

Since Specialization

Citations

This map shows the geographic impact of Sean Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Turner more than expected).

Fields of papers citing papers by Sean Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Turner. The network helps show where Sean Turner may publish in the future.

Co-authorship network of co-authors of Sean Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Turner. A scholar is included among the top collaborators of Sean Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Turner. Sean Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a pharmacy ‘patient prioritization tool’ for use in a Tertiary Paediatric Hospital 2020 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Sean Turner, Alka B. Garg	2
2	Stability of an extemporaneously compounded minoxidil oral suspension 2018 ·American Journal of Health-System Pharmacy ·Yunmei Song, (unknown), David Ellis, (unknown), Sean Turner, D. B. Williams, Sanjay Garg	5
3	Anticonvulsant effects of structurally diverse GABAB positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model 2015 ·Neuropharmacology ·(unknown), (unknown), Martin Schmidt, Sean Turner, Volker Nimmrich, Junli Ma, Lynne E. Rueter, (unknown), Min Zhang	15
4	A national study of the processes and outcomes of paediatric formulary applications in Australia 2014 ·The Medical Journal of Australia ·Yashwant Sinha, Jonathan C. Craig, Peter Barclay, Hugh Miller, Sean Turner, (unknown), Jo‐anne E Brien	3
5	Paediatric Pharmacy in Australia: Where Have We Come From and Where Do We Need To Go? 2013 ·Journal of Pharmacy Practice and Research ·Sonya Stacey, Sean Turner, Kingsley Coulthard, Hugh Miller	5
6	Microwave-Assisted Synthesis of Nitro-Substituted Tetrahydropyridoazepines 2010 ·Synthesis ·Wilfried M. Braje, Thomas Schultz, Sean Turner	2
7	α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model 2007 ·Bioorganic & Medicinal Chemistry Letters ·Arthur Gomtsyan, Erol K. Bayburt, Ryan G. Keddy, Sean Turner, (unknown), Stanley DiDomenico, Richard J. Perner, John R. Koenig, Irene Drizin, Heath A. McDonald, Carol S. Surowy, Prisca Honoré, Joe Mikusa, Kennan C. Marsh, Jill M. Wetter, Connie R. Faltynek, Chih‐Hung Lee	26
8	Incidence of Vancomycin‐Induced Red Man Syndrome in a Women's and Children's Hospital 2007 ·Journal of Pharmacy Practice and Research ·(unknown), (unknown), Sean Turner, Kingsley Coulthard, Ross A. McKinnon	5
9	Impact of an Educational Program on Antibiotic Use in Paediatric Appendectomy Procedures 2005 ·Journal of Pharmacy Practice and Research ·(unknown), V Bruce Sunderland, Malcolm Roberts, Sean Turner, (unknown)	4
10	In vitro and in vivo characterization of a novel naphthylamide ATP‐sensitive K⁺ channel opener, A‐151892 2004 ·British Journal of Pharmacology ·Murali Gopalakrishnan, Steven A. Buckner, Char‐Chang Shieh, Thomas A. Fey, (unknown), Kristi L. Whiteaker, Rachel Davis‐Taber, Ivan Milicic, A.V. Daza, Victoria Scott, Neil A. Castle, David Printzenhoff, (unknown), Sean Turner, William A. Carroll, James P. Sullivan, Michael J. Coghlan, Michael E. Brune	8
11	The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure–activity relationships of 2-amino-4-azaindoles 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sean Turner, William A. Carroll, (unknown), Murali Gopalakrishnan, Michael J. Coghlan, Char‐Chang Shieh, Xufeng Zhang, (unknown), Steven A. Buckner, Ivan Milicic, James P. Sullivan	18
12	Structure–activity relationship of a novel class of naphthyl amide KATP channel openers 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sean Turner, William A. Carroll, (unknown), Michael E. Brune, Steven A. Buckner, Murali Gopalakrishnan, (unknown), Michael J. Coghlan, Victoria Scott, Neil A. Castle, A.V. Daza, Ivan Milicic, James P. Sullivan	5
13	A new class of histamine H3-Receptor antagonists: synthesis and structure–Activity relationships of 7,8,9,10-Tetrahydro-6H-cyclohepta[b]quinolines 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sean Turner, Timothy A. Esbenshade, Youssef L. Bennani, Arthur A. Hancock	14
14	Early Experience with the Use of Celecoxib in a Child and Adolescent Population 2002 ·Journal of Pharmacy Practice and Research ·(unknown), Sean Turner	4
15	Enantiospecific Synthesis of Annulated Nicotine Analogues from d-Glutamic Acid. 7-Azabicyclo[2.2.1]heptano[2.3-c]pyridines 2001 ·The Journal of Organic Chemistry ·(unknown), Sean Turner, Henry Rapoport	27
16	ChemInform Abstract: Enantiospecific Synthesis of Annulated Nicotine Analogues from D‐ and L‐Glutamic Acid. Pyridotropanes. 2000 ·ChemInform ·Sean Turner, Hongbin Zhai, Henry Rapoport	1
17	Enantiospecific Synthesis of Annulated Nicotine Analogues from d- and l-Glutamic Acid. Pyridotropanes 2000 ·The Journal of Organic Chemistry ·Sean Turner, Hongbin Zhai, Henry Rapoport	37
18	Unregistered and Off‐Label Drug Use in Paediatric Inpatients 1999 ·The Australian Journal of Hospital Pharmacy ·Sean Turner	24
19	Cost Implications of Using Inhaled Nitric Oxide Compared with Epoprostenol for Pulmonary Hypertension 1995 ·Journal of Pharmacy Technology ·Andy Petros, Sean Turner, Anthony J Nunn	8
20	The synthesis of substituted pyrrolidines by a samarium (II) iodide mediated ring closure. 1992 ·Tetrahedron Letters ·Jack E. Baldwin, Sean Turner, Mark G. Moloney	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact